HGN halcygen pharmaceuticals limited

HALCYGEN FILES IND WITH THE US FDA TO BEGIN CLINICALDEVELOPMENT...

  1. 49 Posts.
    HALCYGEN FILES IND WITH THE US FDA TO BEGIN CLINICAL
    DEVELOPMENT AND REGISTRATION OF SUBAITRACONAZOLETM
    Improved anti-fungal targeting $600m market.announcement is worth a read
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.